A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer

2015 ◽  
Vol 47 (6) ◽  
pp. 668-671 ◽  
Author(s):  
Robbert D A Weren ◽  
Marjolijn J L Ligtenberg ◽  
C Marleen Kets ◽  
Richarda M de Voer ◽  
Eugène T P Verwiel ◽  
...  
2012 ◽  
Vol 28 (2) ◽  
pp. 473-480 ◽  
Author(s):  
TAKASHI KUNO ◽  
NAGAHIDE MATSUBARA ◽  
SATOSHI TSUDA ◽  
MASAYOSHI KOBAYASHI ◽  
MIE HAMANAKA ◽  
...  

2005 ◽  
Vol 77 (1) ◽  
pp. 112-119 ◽  
Author(s):  
Susan M. Farrington ◽  
Albert Tenesa ◽  
Rebecca Barnetson ◽  
Alice Wiltshire ◽  
James Prendergast ◽  
...  

2021 ◽  
Author(s):  
Claire Palles ◽  
Edward Chew ◽  
Judith E. Grolleman ◽  
Sara Galavotti ◽  
Christoffer Flensburg ◽  
...  

ABSTRACTInherited defects in base-excision repair (BER) predispose to adenomatous polyposis and colorectal cancer (CRC), yet our understanding of this important DNA repair pathway remains incomplete. By combining detailed clinical, histological and molecular profiling, we reveal biallelic germline loss-of-function (LOF) variants in the BER gene MBD4 to predispose to adenomatous polyposis and –uniquely amongst CRC predisposition syndromes– to myeloid neoplasms. Neoplasms from MBD4-deficient patients almost exclusively accumulate somatic CpG>TpG mutations, resembling mutational signature SBS1. MBD4-deficient adenomas harbour mutations in known CRC driver genes, although AMER1 mutations were more common and KRAS mutations less frequent. We did not find an increased risk for colorectal tumours in individuals with a monoallelic MBD4 LOF variant. We suggest that this condition should be termed MBD4-associated neoplasia syndrome (MANS) and that MBD4 is included in testing for the genetic diagnosis of polyposis and/or early-onset AML.


2008 ◽  
Vol 4 (2) ◽  
pp. 63-71 ◽  
Author(s):  
Mohammad Shekari ◽  
Ranbir Chander Sobti ◽  
Dor Mohammad Kordi Tamandani ◽  
Keyanoosh Malekzadeh ◽  
Pushpinder Kaur ◽  
...  

Gut ◽  
2021 ◽  
pp. gutjnl-2019-320462
Author(s):  
Peter Georgeson ◽  
Bernard J Pope ◽  
Christophe Rosty ◽  
Mark Clendenning ◽  
Khalid Mahmood ◽  
...  

ObjectiveGermline pathogenic variants (PVs) in the DNA mismatch repair (MMR) genes and in the base excision repair gene MUTYH underlie hereditary colorectal cancer (CRC) and polyposis syndromes. We evaluated the robustness and discriminatory potential of tumour mutational signatures in CRCs for identifying germline PV carriers.DesignWhole-exome sequencing of formalin-fixed paraffin-embedded (FFPE) CRC tissue was performed on 33 MMR germline PV carriers, 12 biallelic MUTYH germline PV carriers, 25 sporadic MLH1 methylated MMR-deficient CRCs (MMRd controls) and 160 sporadic MMR-proficient CRCs (MMRp controls) and included 498 TCGA CRC tumours. COSMIC V3 single base substitution (SBS) and indel (ID) mutational signatures were assessed for their ability to differentiate CRCs that developed in carriers from non-carriers.ResultsThe combination of mutational signatures SBS18 and SBS36 contributing >30% of a CRC’s signature profile was able to discriminate biallelic MUTYH carriers from all other non-carrier control CRCs with 100% accuracy (area under the curve (AUC) 1.0). SBS18 and SBS36 were associated with specific MUTYH variants p.Gly396Asp (p=0.025) and p.Tyr179Cys (p=5×10-5), respectively. The combination of ID2 and ID7 could discriminate the 33 MMR PV carrier CRCs from the MMRp control CRCs (AUC 0.99); however, SBS and ID signatures, alone or in combination, could not provide complete discrimination (AUC 0.79) between CRCs from MMR PV carriers and sporadic MMRd controls.ConclusionAssessment of SBS and ID signatures can discriminate CRCs from biallelic MUTYH carriers and MMR PV carriers from non-carriers with high accuracy, demonstrating utility as a potential diagnostic and variant classification tool.


Sign in / Sign up

Export Citation Format

Share Document